Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Milestone Pharmaceuticals Inc’s stock clocked out at $1.43, down -2.72% from its previous closing price of $1.47. In other words, the price has decreased by -$2.72 from its previous closing price. On the day, 0.65 million shares were traded. MIST stock price reached its highest trading level at $1.4839 during the session, while it also had its lowest trading level at $1.405.
Ratios:
To gain a deeper understanding of MIST’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 19.13 and its Current Ratio is at 19.13. In the meantime, Its Debt-to-Equity ratio is 1.67 whereas as Long-Term Debt/Eq ratio is at 1.65.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on August 22, 2024, initiated with a Buy rating and assigned the stock a target price of $9.
On June 20, 2023, Jefferies Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $8 to $4.
Piper Sandler Upgraded its Neutral to Overweight on April 22, 2022, whereas the target price for the stock was revised from $8 to $10.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MIST now has a Market Capitalization of 76175528 and an Enterprise Value of 64638620.
Stock Price History:
Over the past 52 weeks, MIST has reached a high of $3.52, while it has fallen to a 52-week low of $1.12. The 50-Day Moving Average of the stock is -2.98%, while the 200-Day Moving Average is calculated to be -7.61%.
Shares Statistics:
It appears that MIST traded 117.36K shares on average per day over the past three months and 221300 shares per day over the past ten days. A total of 53.27M shares are outstanding, with a floating share count of 50.39M. Insiders hold about 5.40% of the company’s shares, while institutions hold 52.65% stake in the company. Shares short for MIST as of 1727654400 were 436935 with a Short Ratio of 3.72, compared to 1724976000 on 382558. Therefore, it implies a Short% of Shares Outstanding of 436935 and a Short% of Float of 0.83.
Earnings Estimates
The current rating of Milestone Pharmaceuticals Inc (MIST) reflects the combined expertise of 3.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.17, with high estimates of -$0.14 and low estimates of -$0.22.
Analysts are recommending an EPS of between -$0.54 and -$0.74 for the fiscal current year, implying an average EPS of -$0.63. EPS for the following year is -$0.86, with 3.0 analysts recommending between -$0.52 and -$1.37.
Revenue Estimates
Based on 3 analysts’ estimates, the company’s revenue will be $5.6M in the next fiscal year. The high estimate is $10.8M and the low estimate is $1.8M.
